PARENTAL CONCERNS OF THEIR SEXUAL AND GENDER MINORITY ADOLESCENTS USING HIV PRE-EXPOSURE PROPHYLAXIS

被引:3
|
作者
Owens, Christopher [1 ,2 ]
Brandenburg, Dakota [3 ]
Grant, Morgan J. [1 ,2 ]
Carter, Kaileigh [1 ]
Hoffman, Matt [4 ]
Hubach, Randolph D. [3 ]
机构
[1] Texas A&M Univ, Sch Publ Hlth, Dept Hlth Behav, 212 Adriance Lab Rd,Sch Publ Hlth Adm Bldg, College Stn, TX 77843 USA
[2] Texas A&M Univ, Sch Publ Hlth, Ctr Hlth Equ & Evaluat Res, College Stn, TX 77843 USA
[3] Purdue Univ, Coll Hlth & Human Sci, Dept Publ Hlth, W Lafayette, IN 47907 USA
[4] Texas A&M Univ, Sch Nursing, College Stn, TX 77843 USA
关键词
PrEP; parents; sexual and gender minority adolescents; concerns; questions; UNITED-STATES; PREP; IMPACT; YOUTH; MEN; COMMUNICATION; WILLINGNESS; PREFERENCES; MEDICATIONS; PREVENTION;
D O I
10.1521/aeap.2023.35.1.85
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Although parents of sexual and gender minority (SGM) adolescents are key stakeholders in SGM adolescents using HIV pre-exposure prophylaxis (PrEP), there is limited understanding of parental concerns and attitudes about their SGM adolescents taking PrEP. Fifty-four parents in the West South Central region of the U.S. completed an online, mixed-method, cross-sectional questionnaire to explore their concerns and questions about PrEP. Quantitative and qualitative results show that participants were more concerned about side effects, drug interactions, (non)adherence, and eligibility and duration of PrEP. Parents are less worried about picking PrEP from a pharmacy or returning to follow-up lab testing every three months. Most parents reported receiving medication information their adolescent takes from a medical provider and the media. Findings from this study can inform the development of parent-based PrEP interventions. Without further parent-based research and programming, SGM adolescents may continue to be disproportionately affected by HIV.
引用
收藏
页码:85 / 99
页数:15
相关论文
共 50 条
  • [21] No evidence of sexual transmission of HEV among individuals using HIV pre-exposure prophylaxis
    Migueres, Marion
    Ducours, Mailys
    Dimeglio, Chloe
    Trimoulet, Pascale
    Abravanel, Florence
    Delobel, Pierre
    Cazanave, Charles
    Izopet, Jacques
    [J]. JOURNAL OF VIRAL HEPATITIS, 2020, 27 (12) : 1495 - 1501
  • [22] Pre-Exposure Prophylaxis for HIV Upfront
    de Mendoza, Carmen
    [J]. AIDS REVIEWS, 2011, 13 (01) : 57 - 58
  • [23] Pre-Exposure Prophylaxis and HIV Incidence
    Mann, Samuel
    [J]. B E JOURNAL OF ECONOMIC ANALYSIS & POLICY, 2023, 23 (04): : 1163 - 1173
  • [24] HIV moments and pre-exposure prophylaxis
    Grant, Robert M.
    Glidden, David V.
    [J]. LANCET, 2016, 387 (10027): : 1507 - 1508
  • [25] Modeling HIV Pre-Exposure Prophylaxis
    Straubinger, Thomas
    Kay, Katherine
    Bies, Robert
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [26] Prescribing pre-exposure prophylaxis for HIV
    Bloch, Mark
    [J]. AUSTRALIAN PRESCRIBER, 2020, 43 (06) : 200 - 203
  • [27] SOCIAL JUDGMENTS OF SEXUAL BEHAVIOR AND USE OF HIV PRE-EXPOSURE PROPHYLAXIS
    Martinez, Joel E.
    Jonas, Kai J.
    [J]. SOCIAL COGNITION, 2020, 38 (01) : 1 - 20
  • [28] HIV pre-exposure prophylaxis in women
    Haberl A.
    [J]. MMW - Fortschritte der Medizin, 2017, 159 (Suppl 2) : 42 - 44
  • [29] Pre-exposure prophylaxis to HIV in practice
    Buxeraud, Jacques
    [J]. ACTUALITES PHARMACEUTIQUES, 2016, 55 (554): : 8 - 8
  • [30] HIV pre-exposure prophylaxis (PrEP)
    Tumarkin, Ethan
    Siedner, Mark J.
    Bogoch, Isaac I.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 364